|
|
Bone CancerBone Cancer—HumansMurphy GP, Troychak MJ, Cobb OE, Bowes VA, Kenny RJ, Barren RJ, Kenny GM, Ragde H, Holmes EH, Wolfert RL. The evaluation of PSA, free-PSA, PSMA, total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer. Prostate 1997; 33(2):141-146. Cortex EP, Chu TM, Wang JJ, Holyoke D, Wallace HJ, Murphy GP. Carcinoembryonic antigen in osteosarcoma. J Surg Oncol 1977; 9(3):257-265. Bone Cancer—Dog SutdiesCooley DM, Beranek BC, Schlittler DL, Glickman NW, Glickman LT, Waters DJ . Endogenous gonadal hormone exposure and bone sarcoma risk. Cancer Epidemiol Biomarkers Prev 2002; 11:1434-40. Pirie-Shepherd SR, Coffman KT, Resnick D, Chan R, Kisker O, Folkman J, Waters DJ. The role of angiostatin in the spontaneous bone and prostate cancers of pet dogs. Biochem Biophys Res Comm 2002; 292:886-91. Cooley DM, Waters DJ. Skeletal metastasis as the initial clinical manifestation of metastatic carcinoma in 19 dogs. J Vet Intern Med 1998; 12:288-293. Hawthorne JC, Cooley DM, Waters DJ. Malignant skeletal neoplasms of dogs. Kleintierpraxis 1997; 42:809-824. Cooley DM, Waters DJ. Skeletal neoplasms of small dogs: a retrospective study and literature review. J Am Anim Hosp Assoc 1997; 33:11-23. |